申请人:Adir et Compagnie
公开号:US05189045A1
公开(公告)日:1993-02-23
The invention relates to new compounds of formula I: ##STR1## in which: m represents zero, 1, 2, 3 or 4, n and p represent zero, 1 or 2, W represents an oxygen atom, an --NH-- radical, or a single bond, R represents a benzocyclobuten-1-yl radical, or an indanyl radical, a 2,3-dihydrobenzofuran-2-yl R.sub.1 represents a hydrogen atom, an alkyl radical having from 1 to 6 carbon atoms, or an aryl radical, and R.sub.2 represents a hydrogen atom, an alkyl radical, an alkenyl radical, a cycloalkyl radical, a benzyl radical, a phenyl radical, an aralkyl radical, an alkoxyalkyl radical or a polyhalogenated alkyl radical, the optical isomers thereof and the addition salts thereof with a pharmaceutically acceptable organic or mineral acid, and medicaments containing the same.
该发明涉及公式I的新化合物:##STR1## 其中:m表示零,1,2,3或4,n和p表示零,1或2,W表示氧原子,--NH--基团或单键,R表示苯并环丁-1-基基团或茚基基团,2,3-二氢苯并呋喃-2-基团,R.sub.1表示氢原子,具有1至6个碳原子的烷基基团或芳基基团,R.sub.2表示氢原子,烷基基团,烯基基团,环烷基基团,苯甲基基团,苯基基团,芳基烷基基团,烷氧基烷基基团或多卤代烷基基团,其光学异构体及其与药学上可接受的有机或无机酸的加成盐和含有它们的药物。